Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

69.94
Delayed Data
As of 4:00pm ET
 +0.57 / +0.82%
Today’s Change
65.38
Today|||52-Week Range
103.10
-2.33%
Year-to-Date
3 Incredibly Cheap Biotech Stocks
8:10am / MotleyFool.com - Paid Partner Content
Gilead Sciences Raises Dividend by Double Digits
Feb 22 / GuruFocus News - Paid Partner Content
United Therapeutics (UTHR) Down on Q4 Earnings & Sales Miss
Feb 23 / Zacks.com - Paid Partner Content
3 Things Gilead Sciences' CEO Just Said That You'll Want to Know
Feb 22 / MotleyFool.com - Paid Partner Content
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Communi...
Feb 22 / GuruFocus News - Paid Partner Content
3 Beaten-Up Dividend Stocks: Are They Bargains?
Feb 22 / MotleyFool.com - Paid Partner Content
Who Could Buy Bristol-Myers Squibb?
Feb 22 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising
Feb 22 / Zacks.com - Paid Partner Content
Numeric Investors Llc Buys Gilead Sciences, Microsoft, Apple, Sells Facebook, Symante...
Feb 22 / GuruFocus News - Paid Partner Content
Sarepta Leads Biotech Movers on Voucher Deal News
Feb 21 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close69.37
Today’s open69.32
Day’s range69.05 - 70.07
Volume7,378,933
Average volume (3 months)10,513,770
Market cap$91.4B
Dividend yield2.97%
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-25.41%
Earnings growth (next 5 years)-2.50%
Revenue growth (last year)-5.14%
P/E ratio6.5
Price/Sales3.20
Price/Book4.69

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+0.38+0.13%
AMGNAmgen+0.55+0.32%
ILMNIllumina Inc-1.01-0.63%
BIVVBioverativ Inc+1.40+2.82%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$2.26
Annual revenue (last year)$30.4B
Annual profit (last year)$13.5B
Net profit margin44.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts


Search for Jobs